New Ray Medicine International Holding Limited (HKG:6108)
Hong Kong
· Delayed Price · Currency is HKD 0.214
+0.001 (0.47%)
Last updated: Mar 9, 2026, 2:42 PM HKT
HKG:6108 Revenue
New Ray Medicine International Holding had revenue of 44.70M HKD in the half year ending June 30, 2025, with 44.12% growth. This brings the company's revenue in the last twelve months to 121.93M, up 240.05% year-over-year. In the year 2024, New Ray Medicine International Holding had annual revenue of 93.95M with 87.31% growth.
Revenue (ttm)
121.93M
Revenue Growth
+240.05%
P/S Ratio
0.35
Revenue / Employee
4.06M
Employees
30
Market Cap
42.93M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 93.95M | 43.79M | 87.31% |
| Dec 31, 2023 | 50.15M | -39.62M | -44.13% |
| Dec 31, 2022 | 89.77M | -245.61M | -73.23% |
| Dec 31, 2021 | 335.38M | 202.17M | 151.76% |
| Dec 31, 2020 | 133.21M | 14.58M | 12.29% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Universal Health International Group Holding | 597.78M |
| Pa Shun International Holdings | 94.69M |
| China Healthwise Holdings | 103.70M |
| Tycoon Group Holdings | 951.11M |
| Kingworld Medicines Group | 1.03B |
| Shanghai Pioneer Holding | 1.49B |
| Fangzhou | 3.15B |
| YSB Inc. | 20.75B |